Objectives. This study was designed to ascertain whether cardiodepressive mediators released after ischemia originate from coronary endothelial cells.
Both clinical and experimental studies have shown that reperfusion after myocardial ischemia produces direct injury and triggers the release of various mediators, including leukocytederived oxygen free radicals, arachidonic acid, cytokines and cytotoxic enzymes (1) (2) (3) (4) (5) .
Recently, we have shown that after global ischemia in an isolated heart, cardiodepressive mediators are released during reperfusion from myocardial tissue, and these mediators then induce a rapid decrease in contractility of a sequentially perfused nonischemic second heart (6). The second heart was used as a bioassay to further characterize the effects of these mediators. However, no conclusion could be drawn from these data on the cellular source of the involved mediators.
Numerous studies have shown that myocardial contractility is modulated by coronary and endocardial endothelial cells (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . The underlying mechanisms are still under investigation. Besides currently accepted mediators released from endothelial cells, such as endothelin (19 -22) , nitric oxide (23) (24) (25) (26) and prostacyclin (18) , other unidentified cardioactive substances upregulating or downregulating myocardial contractility are discussed (13) . Furthermore, endothelial cells may contribute to cardiac malfunction during ischemia and reperfusion. Interestingly, endothelial cells incubated under hypoxic conditions release mediators that induce a pronounced decrease in contractility in superfused isolated myocytes (27) .
The purpose of the study was to ascertain in a double-heart model the role of coronary endothelial cells in modulating myocardial contractile function after ischemia. After a global stop flow-ischemia of 10 min reperfusion was performed in isolated hearts, and the effects of the coronary effluent on contractile function were characterized in sequentially perfused hearts. To verify whether the vascular endothelial cells are the source of mediators released during reperfusion, the coronary endothelial cells of the first heart were damaged by two different techniques.
Methods
Perfusion of two isolated rat hearts-"double-heart model" (Fig. 1) . Rats (Charles River, Germany) of either gender weighing 200 to 300 g were killed mechanically. The hearts were excised and perfused separately according to the Langendorff technique at a constant flow rate of 10 ml/min with a modified Krebs-Henseleit solution (in mmol/liter-NaCl 127.1, KCl 4.7, MgSO 4 1.1, KH 2 PO 4 1.19, NaHCO 3 24.9, CaCl 2 1.26, glucose 8.93, HEPES 10), equilibrated with 95% oxygen and 5% carbon dioxide at 37°C, pH 7.4. Left and right ventricular pressures were recorded by means of a fluid-filled latex balloon inserted through the mitral and tricuspid valves and attached to a pressure transducer (Spectramed, Germany) and chart recorder. The left ventricular end-diastolic pressure was maintained at 5 mm Hg. The balloon pressure was electronically differentiated to yield the rate of intraventricular pressure development (dP/dt) and heart rate. Coronary flow rates were monitored with an ultrasound flowmeter (Transsonic) connected to a flow probe, which was inserted into the aortic arch. Coronary perfusion pressure was monitored with a pressure transducer attached to the aortic perfusion cannula. All variables were continuously displayed. Continuous registration included heart rate, left ventricular pressure (LVP), left ventricular end-diastolic pressure, left ventricular peak positive dP/dt (LVdP/dt max ), left ventricular peak negative dP/dt (LVdP/dt min ), right ventricular pressure (RVP), right ventricular peak positive dP/dt (RVdP/dt max ), right ventricular peak negative dP/dt (RVdP/dt min ), coronary flow rates and coronary perfusion pressure.
After an equilibration period at separate perfusion, the two hearts were sequentially perfused according to the technique described by Schrader and Bardenheuer (28) . The coronary effluent of the first heart was reoxygenated in a microchamber and transported to the second heart by a roller pump. The coronary flow rates of the second heart were adjusted to the flow rates of the first heart by means of electronic processing. This was established by a photodiode incorporated into the microchamber controlling the speed of the pump. Reoxygenation and the transit time of the coronary effluent from the first to the second heart had been reduced (Ͻ3 s) by miniaturization of the oxygenator (Ͻ500 l) and the connecting tubes (inner diameter 0.5 mm). With a system of valves and pumps, it was possible to achieve different perfusion modes: separate perfusion at constant pressure, separate perfusion at constant flow and sequential perfusion (Fig. 1) .
Ethics. All animals received humane care, as described in "Principles of Laboratory Animal Care," formulated by the National Society for Medical Research, and the "Guide for the Care and Use of Laboratory Animals," prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication no. 80-23, revised 1985) .
Methods for damaging endothelial cells. Two different methods were applied to damage endothelial cells. In some experiments, the coronary endothelium was selectively destroyed by a 10-s intracoronary infusion of Triton X-100 dissolved in a Krebs-Henseleit solution at a dilution of 1:200. The infusion rate of Triton X-100 was 1% of the coronary flow rate. After this procedure, the hearts were allowed to reequilibrate for 20 min. The amount of Triton X-100 necessary to damage the coronary endothelium was established after several pilot experiments. Endothelial damage was confirmed with electron microscopy. In addition, the effectiveness of Triton X-100 to also abolish the physiologic function of the coronary vascular endothelium was verified by endothelialdependent and -independent vasodilation before and after Triton X-100 infusion. The second procedure to damage coronary endothelial cells has been described in detail by Griffith et al. (29) and Ramaciotti et al. (13) . After equilibration, the perfusion of the hearts was switched to a high potassium Krebs-Henseleit solution (replacing 40 mmol/liter of NaCl with 40 mmol/liter of KCl) infused over 10 min. Within 15 s of initiating the high potassium perfusion, the hearts went into contracture and mean perfusion pressure rose to 200 mm Hg. This procedure has been reported to damage coronary endothelial cells of the arterioles and to eliminate the
Abbreviations and Acronyms
ϭ rate of intraventricular pressure development GTN ϭ glyceryl trinitrate LVdP/dt max (LVdP/dt min ) ϭ left ventricular peak positive (negative) dP/dt LVP ϭ left ventricular pressure RVdP/dt max (RVdP/dt min ) ϭ right ventricular peak positive (negative) dP/dt RVP ϭ right ventricular pressure Figure 1 . Schematic illustration of the double-heart model. Separate perfusion at constant pressure is performed by opening V1 and V2. After closure of V1 and V2 the perfusion mode is switched to perfusion at constant flow by means of P1 and P2. Serial perfusion is realized by closure of P2 and opening of V3, while the coronary effluent of heart I is collected and reoxygenized in the microchamber and then transported to heart II by P3. The coronary flow rates of heart II are adjusted to those of heart I by means of electronic processing. K-H ϭ Krebs-Henseleit; P ϭ roller pump; V ϭ valve.
decrease in coronary resistance produced by cholinergic drugs (29) . Capillaries and venules were not damaged and maintained a normal appearance. Furthermore, transmission electron microscopic studies have confirmed that no normal endothelial cells remained within the arterial vasculature (13, 29) . At the end of hyperkalemic perfusion, the hearts were again perfused with normal Krebs-Henseleit solution and contractile function was reestablished within 5 min. Functional investigation of the vascular integrity and contractile function before and after selective endothelial damage. The coronary response to the endothelial-independent vasodilators glyceryl trinitrate (GTN, 1 mol/liter, n ϭ 3) and papaverine (5 mol/liter, n ϭ 4) and to the endothelialdependent vasodilators 5-hydroxytryptamine (5-HT, 1 mol/ liter, n ϭ 4) and bradykinin (1 mol/liter, n ϭ 3) was investigated under basal conditions by means of intracoronary infusion in isolated rat hearts while being perfused at constant pressure (80 cm H 2 O). The perfusion mode was then switched to perfusion at a constant flow rate of 10 ml/min, and Triton X-100 was intracoronarily infused as described earlier. At the end of the recovery period after administration of Triton X-100, the perfusion mode was switched once more to perfusion at constant pressure and the effects of the endothelialdependent and -independent vasodilators were examined.
In additional series of experiments, the contractile response of the isolated hearts to the beta-receptor agonist isoproterenol (5 nmol/liter, n ϭ 4) was investigated before and after infusion of Triton-X 100.
Experimental protocol. The hearts were perfused at a constant flow rate of 10 ml/min for 40 min. This was followed by sequential perfusion with (group I) or without (control group) preceding stop flow-ischemia (10 min) of the first heart, as described in Figure 2 . In groups II and III, the coronary endothelium of the first heart was damaged before initiating global ischemia by Triton X-100 infusion or by hyperkalemic perfusion, respectively.
In subsequent series of experiments, heart I was treated with an intracoronary infusion of either free radical scavengers (catalase and superoxide dismutase, 100 U/ml, n ϭ 4) or a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine, 100 mol/liter, n ϭ 5). The infusion was started 20 min before ischemia and was continued until the end of the experiment. Furthermore, in four experiments, the second heart was pretreated with an adenosine A 1 (1,3-dipropyl-8-cyclopentylxanthine [DPCPX], 1 mol/liter) and A 2 (3,7-dimethyl-1-propargylxanthine [DMPX], 1 mol/liter) receptor antagonist over a period 20 min before and during sequential perfusion. Transmission electron microscopy. In separate experiments, three hearts of each group were perfusion-fixed at the end of the experiments. The fixative contained 0.1 mol/liter of phosphate buffer and 2.5% glutaraldehyde at pH 7.3. Sections of 1 mm 3 were cut from the hearts and stored in 0.1 mol/liter of phosphate buffer at pH 7.3 at 4°C. Samples were postfixed with osmium tetroxide and dehydrated in an ascending series of ethanol and embedded in epoxy resin. Sections of 1 m thickness, stained with toluidine blue, were examined before sections for electron microscopy were cut. Ultrathin sections, stained with uranyl acetate and lead citrate, were examined and photographed with Zeiss EM 900 operated at 80 kV.
Drugs. Triton X-100 was obtained from Ferax (Berlin, Germany) and GTN from Schwarz Pharma (Monheim, Germany). Isoproterenol, papaverine, bradykinin, 5-HT, catalase, superoxide dismutase and N-omega-nitro-L-arginine were obtained from Sigma Chemical (Deisenhofen, Germany), and DPCPX and DMPX from Research Biochemicals International.
Statistical analysis. Results are expressed as mean value Ϯ SEM for number of determinations. Nonparametric repeated measures analysis of variance with data alignment was performed for comparison of certain groups of interest. After global testing, a multiple comparison procedure using the Bonferroni-Holm adjustment of alpha was carried out.
Results
Effect of Triton X-100 on the contractile function of isolated buffer perfused rat hearts. Before Triton X-100 treatment, all contractile variables were stable at baseline (LVP 66 Ϯ 6 mm Hg, LVdP/dt max 3,093 Ϯ 413 mm Hg/s and LVdP/dt min Ϫ1,491 Ϯ 208 mm Hg/s). These variables significantly decreased during Triton X-100 treatment and then completely recovered within 10 min. Coronary perfusion pressure markedly increased and stabilized at a new baseline of 120 Ϯ 11 cm H 2 O before serial perfusion. The effect of an intracoronary infusion of isoproterenol (5 nmol/liter) before and after Triton X-100 infusion is shown in Figure 3 . Isoproterenol before the endothelial damage induced an increase of LVP by 22% and of LVdP/dt max by 36%. After Triton X-100 treatment, the response of these contractile variables to isoproterenol infusion was only slightly reduced (LVP increased by 18% and LVdP/ dt max increased by 28%). This indicates that the contractile apparatus was still intact and the sarcolemmal beta-receptors Figure 2 . Experimental protocol. In the control group, sequential perfusion was performed without preceding ischemia of heart I. In groups I to III, serial perfusion was started after 10-min global ischemia of heart I.
as well as the beta-receptor signal transduction to the contractile apparatus was not significantly influenced by Triton X-100.
Effects of endothelial-dependent and -independent vasodilators on rat coronary vasculature before and after Triton X-100 infusion (Fig. 4) . Before Triton X-100, the infusion of all vasodilators induced rapid and pronounced coronary vasodilation. After Triton X-100, the endothelial-dependent vasodilators bradykinin and 5-HT caused a pronounced vasoconstriction, suggesting that the coronary endothelium is severely damaged and dysfunctional. In contrast, the vasodilative effect of the endothelial-independent vasodilators GTN and papaverine was not modulated by Triton X-100, suggesting that the smooth muscle cells were still intact (Fig. 4) .
Ultrastructural damage in rat hearts produced by Triton X-100. Figures 5 and 6 illustrate representative capillaries from a control heart and a Triton X-100 -treated heart. The control capillary reveals an intact smooth endothelial cell and normal appearance of cellular organelles and membranes. The capillary from the treated heart shows destruction in the endothelial monolayer with characteristic multiple perforations in the endothelial cell, pinocytotic vesicles within the endothelial cell and surrounding tissue, some distortion of the endothelial cell, as well as separation of the capillary from surrounding tissue. The damage includes loss of cell cytoplasm and severe disruption of the endothelial cell junctions, whereas cell junctions from the control capillaries have a normal overlapping appearance. Subjacent myocytes as well as smooth muscle cells were undamaged by this treatment.
Hemodynamic changes observed in the second heart during serial perfusion. In the control group (n ϭ 9), the LVP (75 Ϯ 4 mm Hg), LVdP/dt max (2,805 Ϯ 152 mm Hg/s), LVdP/dt min (Ϫ1,447 Ϯ 100 mm Hg/s), coronary perfusion pressure (78 Ϯ 2 cm H 2 O) and heart rate (281 Ϯ 13 beats/min) of heart II were similar at baseline to the corresponding variables of heart I. No relevant changes of these variables were observed during serial perfusion under control conditions (Fig. 7) . In contrast, in group I (n ϭ 7), after 10 min of global ischemia of heart I, the LVP (basal 77 Ϯ 6 mm Hg) of heart II immediately decreased by 55%, LVdP/dt max (basal 2,790 Ϯ 257 mm Hg/s) by 66% and LVdP/dt min (Ϫ1,667 Ϯ 90 mm Hg/s) by 70% when reperfusion was initiated. These variables increased again to baseline levels within 10 min. Heart rate and coronary perfusion pressure did not change significantly. After creating selective endothelial damage to the first heart before global ischemia in groups II (n ϭ 6) and III (n ϭ 6), the decrease of the contractile variables at the onset of serial perfusion in heart II was not significantly different compared with that in group I. However, in group II, in contrast to the other groups, LVP and LVdP/dt did not recover completely, and reached a new plateau of 20% below baseline before ischemia. Furthermore, in this group there was also a slight but significant decrease in coronary perfusion pressure during the early phase of sequential perfusion. The negative inotropic effect was modulated by neither pretreatment of heart I with N-omega-nitro-L-arginine nor an infusion of free radical scavengers (superoxide dismutase and catalase). Furthermore, the adenosine receptor antagonists, infused either alone or in combination into heart II, did not significantly influence the contractile response of heart II at the onset of serial perfusion after a 10-min global ischemia of heart I. Therefore, neither adenosine, nitric oxide nor free radicals play a major role in the observed decrease in contractility in heart II.
Discussion
The data presented show that, independent of the effect of blood cells, a release of mediators from myocardial tissue may contribute to contractile dysfunction after ischemia. Using a Changes in left ventricular contractile variables in heart II exposed to sequential perfusion without preceding ischemia of heart I (control group) and after a 10-min global ischemia of heart I (groups I to III). In groups II and III the coronary endothelium of heart I was damaged by Triton X-100 pretreatment and hyperkalemic infusion, respectively. A, Left ventricular dP/dt max (LVdP/dt max ). B, Left ventricular dP/dt min (LVdP/dt min ). Significant global differences were demonstrated with respect to the effects between the groups. Moreover, multiple testing of the same effect resulted in significant differences between the control hearts and the remaining groups. The comparisons in the following mode did not yield significant differences: Significant results were also found for changes within subjects (time) and for interactions (groups ϫ time) with p Ͻ 0.001 in all comparisons (global and multiple adjusted).
model of sequential perfusion of two isolated hearts, the effects of cardiodepressive agents released after global ischemia during reperfusion of an isolated heart on a sequentially perfused nonischemic second heart were characterized. During serial perfusion, no relevant changes were observed in the left ventricular contractile variables of the second heart under control conditions. In contrast, when serial perfusion was started after a 10-min global ischemia of the first heart, a marked but reversible decrease in contractility was observed in the second heart despite normoxia. Accordingly, electron microscopy did not show any morphologic changes in the second heart, which suggested that these changes are not due to cellular damage.
Role of endothelial cells. Particular interest was focused on the endothelial cell layer as a potential source of the mediators. The role of the endothelium in the regulation of vascular smooth muscle tone is well established. Furthermore, recent studies suggest that the endothelial cell lining may also influence myocardial contractility (7) (8) (9) (10) (12) (13) (14) . The possible underlying mechanisms are modulation of myofilament calcium responsiveness or affinitiy (18, 30, 31) and release of an upregulating and downregulating factor involving a cyclic adenosine monophosphate-sensitive mechanism for regulating the contractile proteins (32, 33) .
At present, there are few data available on the potential role of endothelial cells with regard to myocardial contractility after ischemia. By creating severe vascular endothelial damage to the first heart by Triton X-100 or hyperkalemic infusion before global ischemia, the role of endothelial cells as a putative source of the mediator(s) was investigated in the double-heart model. The cardiodepressive effect observed after global ischemia of the first heart at the onset of serial perfusion in the second heart did not depend on functional or morphologic integrity of the vascular endothelial cells. Therefore, the negative inotropic mediators released after global ischemia during reperfusion obviously did not originate from coronary endothelial cells.
Furthermore, despite creating endothelial damage to either the second heart or to both hearts, the observed negative inotropic effect in the second heart was not modified. This suggests that the endothelial cell lining does not play a role as a physiologic barrier or have a transmitter role in response to the cardiodepressive mediator released by the first heart in this experimental setup.
Chemical structure of the cardiodepressive mediator. Until now, we have not identified the chemical structure of the mediator(s). Among the known negative inotropic agents released from endothelial cells after ischemia, free radicals, adenosine or nitric oxide may be involved. However, it is unlikely that these mediators would play a role in mediating the cardiodepressive effect described here, because administration of free radical scavengers, adenosine alpha 1 and alpha 2 receptor antagonists and a nitric oxide synthase inhibitor did not influence the hemodynamic changes observed in the second heart at the onset of serial perfusion. Finally, by means of serial analysis and equilibration of pH, partial pressure of oxygen and electrolytes of the coronary effluent of the first heart before sequential perfusion, we were able to exclude the possibility that the hemodynamic changes are caused by ionic changes, acidosis or hypoxia in the coronary effluent of the first heart.
Conclusions. Our data demonstrate that cardiodepressive mediators are released after ischemia during reperfusion. These negative inotropic mediators are not derived from coronary endothelial cell metabolism, because severe selective endothelial damage of the first heart before ischemia does not modulate the observed cardiodepressive effect. As mentioned earlier, known mediators that are released after ischemia and that display negative inotropic effects (i.e., nitric oxide, adenosine and oxygen free radicals) are not involved. Even so, no direct evidence that identifies the structure of these mediators has become available until now. Further studies are necessary to characterize the chemical structure as well as the cellular source of these mediators.
